Higher levodopa doses were associated with a drop in blood pressure among older Parkinson’s patients, those with 65 or more years, in the early and middle stages of the disease, a study reported. Cognitive impairment was identified as a risk factor for a sudden blood pressure drop when…
News
The U.S. Food and Drug Administration (FDA) has approved Boston Scientific’s software called Vercise Neural Navigator 5, which provides visual guidance on how to best program deep brain stimulation (DBS) settings for Parkinson’s disease. The improved software features an enhanced user-friendly interface that presents simplified patient data and…
Plant compounds extracted from the Amomum subulatum fruit, also known as greater cardamom, were found to ease Parkinson’s disease-like symptoms — lessoning tremors and reducing muscular rigidity — in a rat model of features that are hallmarks of the neurodegenerative disorder. The greater cardamom extracts, given orally, worked to increase…
Imaging software developed by Braintale may distinguish Parkinson’s disease from atypical parkinsonism based on measures of early changes in the brain’s white matter, aiding in better diagnoses and disease treatment development. That’s according to initial results from a study into biomarkers on magnetic resonance…
The Parkinson Voice Project (PVP)’s SPEAK OUT! Therapy & Research Center at Northeastern University will receive a $280,000 PVP grant for training, services, equipment, and supplies over the next five years. The four-week program, running at the university’s Speech-Language and Hearing Center for more than two years,…
Using a smartwatch to track how fast people can move may help identify who’s at risk for Parkinson’s disease up to seven years before symptoms become evident and doctors make a diagnosis, a study suggests. Wearing the smartwatch for a week was enough to feed an artificial intelligence (AI)-powered…
Gcanrx soon will open a Phase 2 clinical trial of a neuroprotective cannabinoid treatment that the company expects could benefit people with a range of neurological conditions, including Parkinson’s disease. The safety and efficacy trial, approved to take place in Israel, is expected to begin enrolling children with…
An approach for treating dysphagia — called effortful swallow maneuver — did not consistently ease signs of swallowing difficulties for Parkinson’s disease patients in a small pilot study. Effortful swallow, or ES, refers to a practice where patients are asked to consciously increase the force they use when swallowing…
People with Parkinson’s disease tend to have different coping strategies depending on factors such as age, gender, and education, a new study shows. Findings suggest that differences in demographic and clinical factors, but not differences in coping strategies, are the main factors that determine patients’ quality of life, according…
The Center for Movement Disorders and Neurorestoration at the University of California (UC) Davis Health Department of Neurology will serve as a Parkinson’s Foundation Center of Excellence starting this month and for at least the next five years. The center joins a Global Care Network that’s grown…
Recent Posts
- Balancing safety and individual autonomy in Parkinson’s disease
- Patient visits wrap up in Parkinson’s trial of oral bezisterim therapy
- Brain pathway shows potential for slowing Parkinson’s, but only in females
- Parkinson’s disease forced our family to say the quiet parts out loud
- First US state passes ban on paraquat, herbicide tied to higher Parkinson’s risk